Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01570699 : Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients
PhaseN/A
AgesMin: 35 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patient over 18 years old

- Caucasian patients

- Clinical diagnosis of lifetime opiate-using disorder (consumption over 10 times of
illicit opiates (heroin, buprenorphine, methadone or morphine))

- Not lifetime history of opioid dependence (DSMIV)

- Patients with health insurance coverage

- Patient was treated with opioids analgesics to alleviate 2 or 3 in their lives

Exclusion Criteria:

- Non-Caucasian patients

- Patients who cannot give their consent and/or who refuse the collection of genetic
data

- Patients with no health insurance coverage
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01570699      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740